Health Affairs, 23, no. 5 (2004): 226-232
doi: 10.1377/hlthaff.23.5.226
© 2004 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Shaya, F. T.
* Articles by Mullins, C. D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Shaya, F. T.
* Articles by Mullins, C. D.
Related Collections
* Insurance Coverage - Children
* Business Of Health
* Pharmaceuticals
* Health Spending
* Consumer Issues

Health Tracking

TRENDS

Prescription Drug Spending Trends For The Privately Insured In Maryland, 2000–2001

Fadia T. Shaya, Steven Blume and C. Daniel Mullins

Out-of-pocket drug spending per patient rose 25 percent in 2001 for the privately insured nonelderly in Maryland, outpacing the 10 percent increase in total drug spending per patient. Prescription drug use patterns changed little in response to a 30 percent rise in copayments, with the number of prescriptions per patient decreasing by 3 percent, and the proportion of generic drugs remaining steady. About 23 percent of patients spent less than $50 on drugs in 2001, while 21 percent spent more than $700. Findings suggest that a greater proportion of the economic burden of prescription drugs in coming years will be borne by those who use them.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?